Brain Serotonin Transporter Binding of [¹²³I]ADAM: Within‐Subject Variation between Summer and Winter Data

References

• Backstrom I, Bergstrom M, Marcusson J. High affinity [3H]paroxetine binding to serotonin uptake sites in human brain tissue. Brain Res. 1989; 486: 261–268
   PubMedGoogle Scholar
• Best S E, Sarrel P M, Malison R T, Laruelle M, Zoghbi S S, Baldwin R M, Seibyl J P, Innis R B, van Dyck C H. Striatal dopamine transporter availability with [123I]beta‐CIT SPECT is unrelated to gender or menstrual cycle. Psychopharmacology 2005; 183: 181–189
   PubMedGoogle Scholar
• Carlsson A, Svennerholm L, Winblad B. Seasonal and circadian monoamine variations in human brains examined post mortem. Acta Psychiatr. Scand. Suppl. 1980; 280: 75–85
   PubMedGoogle Scholar
• Catafau A M, Perez V, Penengo M M, Bullich S, Danus M, Puigdemont D, Pascual J C, Corripio I, Llop J, Perich J, Alvarez E. SPECT of serotonin transporters using 123I‐ADAM: Optimal imaging time after bolus injection and long‐term test‐retest in healthy volunteers. J. Nucl. Med. 2005; 46: 1301–1309
   PubMedGoogle Scholar
• DeMet E M, Chicz‐DeMet A, Fleischmann J. Seasonal rhythm of platelet 3H‐imipramine binding in normal controls. Biol. Psychiatry 1989; 26: 489–495
   PubMedGoogle Scholar
• European Commission. Radiation Protection 99. Guidance on Medical Exposures in Medical and Biomedical Research. The Office for Official Publications of the European Communities, Luxembourg 1999; 10–11
   Google Scholar
• Galzin A M, Loo H, Sechter D, Langer S Z. Lack of seasonal variation in platelet [3H]imipramine binding in humans. Biol. Psychiatry 1986; 21: 876–882
   PubMed Web of Science ®Google Scholar
• Kaprio J, Pulkkinen L, Rose R J. Genetic and environmental factors in health‐related behaviors: Studies on Finnish twins and twin families. Twin Res. 2002; 5: 366–371
   PubMedGoogle Scholar
• Kauppinen T A, Bergström K A, Heikman P, Hiltunen J, Ahonen A K. Biodistribution and radiation dosimetry of (123‐I)‐ADAM in healthy human subjects: Preliminary results. Eur. J. Nucl. Med. Mol. Imaging 2003; 30: 132–136
   PubMed Web of Science ®Google Scholar
• Kauppinen T, Koskela A, Diemling M, Keski‐Rakhonen A, Sihvola E, Ahonen A. Comparison of manual and automated quantification methods of 123I‐ADAM. Nuklearmedizin 2005; 44: 205–212
   PubMedGoogle Scholar
• Koskela A K, Keski‐Rahkonen A, Sihvola E, Kauppinen T, Kaprio J, Ahonen A, Rissanen A. Serotonin transporter binding of [123I]ADAM in bulimic women, their healthy twin sisters, and healthy women: A SPET study. BMC Psychiatry 2007; 7: 19
   PubMedGoogle Scholar
• Lam R W, Levitan R D. Pathophysiology of seasonal affective disorder: A review. J. Psychiatry Neurosci. 2000; 25: 469–480
   PubMed Web of Science ®Google Scholar
• Laruelle M, Baldwin R M, Malison R T, Zea‐Ponce Y, Zoghbi S S, al‐Tikriti M S, Sybirska E H, Zimmermann R C, Wisniewski G, Neumeyer J L. SPECT imaging of dopamine and serotonin transporters with [123I]beta‐ CIT: Pharmacological characterization of brain uptake in nonhuman primates. Synapse 1993; 13: 295–309
   PubMed Web of Science ®Google Scholar
• Mathews T A, Fedele D E, Coppelli F M, Avila A M, Murphy D L, Andrews A M. Gene dose‐dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression. J. Neurosci. Methods 2004; 140: 169–181
   PubMed Web of Science ®Google Scholar
• Neumeister A, Pirker W, Willeit M, Praschak‐Rieder N, Asenbaum S, Brucke T, Kasper S. Seasonal variation of availability of serotonin transporter binding sites in healthy female subjects as measured by [123I]‐2 beta‐ carbomethoxy‐3 beta‐(4‐iodophenyl)tropane and single photon emission computed tomography. Biol. Psychiatry 2000; 47: 158–160
   PubMed Web of Science ®Google Scholar
• Neumeyer J L, Tamagnan G, Wang S, Gao Y, Milius R A, Kula N S, Baldessarini R J. N‐substituted analogs of 2 beta‐carbomethoxy‐3 beta‐ (4′‐iodophenyl)tropane (beta‐CIT) with selective affinity to dopamine or serotonin transporters in rat forebrain. J. Med. Chem. 1996; 39: 543–548
   PubMed Web of Science ®Google Scholar
• Oya S, Choi S R, Hou C, Mu M, Kung M P, Acton P D, Siciliano M, Kung H F. 2‐((2‐((dimethylamino)methyl)phenyl)thio)‐5‐iodophenylamine (ADAM): An improved serotonin transporter ligand. Nucl. Med. Biol. 2000; 27: 249–254
   PubMed Web of Science ®Google Scholar
• Ramamoorthy S, Blakely R D. Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants. Science 1999; 285: 763–766
   PubMed Web of Science ®Google Scholar
• Ressler K J, Nemeroff C B. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress. Anxiety 2000; 12(Suppl.1)2–19
   PubMed Web of Science ®Google Scholar
• Spigset O, Allard P, Mjorndal T. Circannual variations in the binding of [3H]lysergic acid diethylamide to serotonin2A receptors and of [3H]paroxetine to serotonin uptake sites in platelets from healthy volunteers. Biol. Psychiatry 1998; 43: 774–780
   PubMed Web of Science ®Google Scholar
• Touitou Y, Smolensky M H, Portaluppi F. Ethics, standards and procedures of animal and human chronobiology research. Chronobiol. Int. 2006; 23: 1083–1096
   PubMed Web of Science ®Google Scholar
• Willeit M, Praschak‐Rieder N, Neumeister A, Pirker W, Asenbaum S, Vitouch O, Tauscher J, Hilger E, Stastny J, Brucke T, Kasper S. [123I]‐beta‐CIT SPECT imaging shows reduced brain serotonin transporter availability in drug‐free depressed patients with seasonal affective disorder. Biol. Psychiatry 2000; 47: 482–489
   PubMed Web of Science ®Google Scholar
• Zahniser N R, Doolen S. Chronic and acute regulation of Na+/Cl− ‐dependent neurotransmitter transporters: Drugs, substrates, presynaptic receptors, and signaling systems. Pharmacol. Ther. 2001; 92: 21–55
   PubMed Web of Science ®Google Scholar